However, Huang et al. 5 confirmed that the low tumor CTLA-4 expression group has a significant longer OS, failure-free survival (FFS), and distant failure-free survival (D-FFS) compared to those groups with high tumor CTLA-4 expression. The gene discussed is CTLA4; the disease is neoplasm.